Comments

Intellia Therapeutics (NTLA) Stock Price, Quote, News & History

NTLANASDAQ

Logo brought to you by Benzinga Data

Trade with Public

$9.12

At close: Dec 17, 4:00 PM EST

$9.13

0.010.11%

After Hours: 7:57 PM EST

Overview

News Earnings Options Analyst Ratings Insider Trades Short Interest Government Trades Stock Report

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Key Statistics

Open

Volume / Avg.

0 / 7.84M

Day Range

- - -

52 Wk Range

5.90 - 28.25

Market Cap

$1.06B

P/E Ratio

Dividend Yield

Exchange

NASDAQ

RSI

Short Interest

43.17%

Days to Cover

9.48

Recent Intellia Therapeutics Inc News

The Short List — Top 10 Most Shorted Stocks Right Now

Here's a look at the top ten most shorted stocks in the market right now, including Wendy's, Lucid and Wolfspeed.

Erica Kollmann

This Bath & Body Works Analyst Is No Longer Bullish; Here Are Top 4 Downgrades For Wednesday

Avi Kapoor

This SPS Commerce Analyst Is No Longer Bullish; Here Are Top 3 Downgrades For Tuesday

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Aug

Sep

Oct

Nov

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

3.2

Hold

Strong Buy

Buy

Hold

Sell

Strong Sell

Key Statistics

Open

Volume / Avg.

0 / 7.84M

Day Range

- - -

52 Wk Range

5.90 - 28.25

Market Cap

$1.06B

P/E Ratio

Dividend Yield

Exchange

NASDAQ

RSI

Short Interest

43.17%

Days to Cover

9.48

About

Sector

Health Care

Industry

Biotechnology

Intellia Therapeutics is a gene-editing company focused on the development of Crispr/Cas9-based therapeutics. Crispr/Cas9 stands for Clustered Regularly Interspaced Short Palindromic Repeats (Crispr)/Crispr-associated protein 9 (Cas9), which is a rev...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry